The recent Annual ASCO Meeting brought us the top oncology research focused on Advancing Equitable Cancer Care Through Innovation.

Without question pharma has made so much progress across multiple investigational programmes to help patients living with cancer.

There have been huge successes which could for example transform the categorisation and treatment of breast cancer and DESTINY-Breast04 received a standing ovation.

Listen to our podcast on the main highlights from #ASCO2022.